Bodycote · GB00B3FLWH99 · BOY | XLON | Prime AI Terminal

Thu, 14.08.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

14 August 2025

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback extension programme announced on 30 July 2025 (the Extended Programme), it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through Jefferies International Limited:

Date of purchase:

13 August 2025

Aggregate number of ordinary shares purchased:

37,337

Highest price paid per share (pence per share):

637.0p

Lowest price paid per share (pence per share):

631.0p

Volume weighted average price paid per share

(pence per share)

633.70p

The Company intends to cancel these Ordinary Shares.

Following the purchase, settlement and cancellation of these Ordinary Shares, the Company will have 176,946,766 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains the detailed breakdown of the individual trades made by Jefferies International Limited on behalf of the Company as part of the Programme.

Since the commencement of this Extended Programme, the Company has purchased a total of 363,638 Ordinary Shares. In addition to the 14,145,768 Ordinary Shares purchased under the Share Buyback Programme between March 2024 and July 2025, the Company has purchased a total of 14,509,406 Ordinary Shares.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Schedule of Purchases

Transaction Details:

Issuer name: Bodycote plc

ISIN: GB00B3FLWH99

LEI: 213800V93QFW53NB7Y29

Intermediary name: Jefferies International Limited

Intermediary code: JEFFGB2XXXX

Time zone: GMT

Currency: GBP

Individual Transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Transaction reference number

Venue

118

637

13/08/2025 08:04:14

00482416320TRLO0.1.1

XLON

27

637

13/08/2025 08:04:14

00482416321TRLO0.1.1

XLON

28

637

13/08/2025 08:08:27

00482417084TRLO0.1.1

XLON

117

637

13/08/2025 08:08:27

00482417083TRLO0.1.1

XLON

145

633.5

13/08/2025 08:12:43

00482417740TRLO0.1.1

XLON

60

631

13/08/2025 08:12:43

00482417741TRLO0.1.1

BATE

145

632

13/08/2025 08:19:00

00482418544TRLO0.1.1

XLON

145

632

13/08/2025 08:25:31

00482419123TRLO0.1.1

XLON

145

632

13/08/2025 08:29:38

00482419540TRLO0.1.1

XLON

61

631

13/08/2025 08:30:45

00482419689TRLO0.1.1

BATE

145

631.5

13/08/2025 08:34:10

00482420019TRLO0.1.1

XLON

34

632

13/08/2025 08:35:26

00482420265TRLO0.1.1

CHIX

34

633.5

13/08/2025 08:39:52

00482420652TRLO0.1.1

CHIX

145

633

13/08/2025 08:39:52

00482420653TRLO0.1.1

XLON

61

634.5

13/08/2025 08:40:03

00482420670TRLO0.1.1

BATE

145

636

13/08/2025 08:43:12

00482420931TRLO0.1.1

XLON

6

636

13/08/2025 08:47:46

00482421463TRLO0.1.1

XLON

139

636

13/08/2025 08:47:46

00482421464TRLO0.1.1

XLON

7

636

13/08/2025 08:50:47

00482421800TRLO0.1.1

CHIX

27

636

13/08/2025 08:50:47

00482421801TRLO0.1.1

CHIX

7

636

13/08/2025 08:53:56

00482422096TRLO0.1.1

CHIX

27

636

13/08/2025 08:58:03

00482422451TRLO0.1.1

CHIX

34

636

13/08/2025 08:58:03

00482422453TRLO0.1.1

TRQX

290

636

13/08/2025 08:58:03

00482422452TRLO0.1.1

XLON

34

636

13/08/2025 08:58:03

00482422454TRLO0.1.1

TRQX

7

636

13/08/2025 09:00:20

00482422664TRLO0.1.1

TRQX

10

636

13/08/2025 09:00:20

00482422665TRLO0.1.1

TRQX

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Tue, 12.08.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

12 August 2025

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback extension programme announced on 30 July 2025 (the Extended Programme), it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through Jefferies International Limited:

Date of purchase:

11 August 2025

Aggregate number of ordinary shares purchased:

37,658

Highest price paid per share (pence per share):

631.0p

Lowest price paid per share (pence per share):

616.5p

Volume weighted average price paid per share

(pence per share)

619.85p

The Company intends to cancel these Ordinary Shares.

Following the purchase, settlement and cancellation of these Ordinary Shares, the Company will have 177,021,043 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains the detailed breakdown of the individual trades made by Jefferies International Limited on behalf of the Company as part of the Programme.

Since the commencement of this Extended Programme, the Company has purchased a total of 289,361 Ordinary Shares. In addition to the 14,145,768 Ordinary Shares purchased under the Share Buyback Programme between March 2024 and July 2025, the Company has purchased a total of 14,435,129 Ordinary Shares.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Schedule of Purchases

Transaction Details:

Issuer name: Bodycote plc

ISIN: GB00B3FLWH99

LEI: 213800V93QFW53NB7Y29

Intermediary name: Jefferies International Limited

Intermediary code: JEFFGB2XXXX

Time zone: GMT

Currency: GBP

Individual Transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Transaction reference number

Venue

2

631

11/08/2025 08:07:40

00482006173TRLO0.1.1

CHIX

31

631

11/08/2025 08:07:40

00482006174TRLO0.1.1

CHIX

278

631

11/08/2025 08:07:40

00482006175TRLO0.1.1

XLON

100

629

11/08/2025 08:10:51

00482007099TRLO0.1.1

XLON

39

629

11/08/2025 08:10:51

00482007100TRLO0.1.1

XLON

11

628.5

11/08/2025 08:12:58

00482007680TRLO0.1.1

CHIX

58

630

11/08/2025 08:13:15

00482007758TRLO0.1.1

BATE

22

628.5

11/08/2025 08:14:19

00482008254TRLO0.1.1

CHIX

20

630

11/08/2025 08:14:28

00482008314TRLO0.1.1

XLON

119

630

11/08/2025 08:14:28

00482008313TRLO0.1.1

XLON

58

630

11/08/2025 08:15:28

00482008740TRLO0.1.1

BATE

139

630

11/08/2025 08:18:03

00482009959TRLO0.1.1

XLON

58

630

11/08/2025 08:19:52

00482010986TRLO0.1.1

BATE

139

630

11/08/2025 08:21:43

00482011838TRLO0.1.1

XLON

33

629

11/08/2025 08:21:44

00482011839TRLO0.1.1

CHIX

139

630

11/08/2025 08:25:18

00482013567TRLO0.1.1

XLON

33

629

11/08/2025 08:25:46

00482013706TRLO0.1.1

CHIX

58

629

11/08/2025 08:26:28

00482014057TRLO0.1.1

BATE

110

630

11/08/2025 08:28:57

00482015106TRLO0.1.1

XLON

29

630

11/08/2025 08:28:57

00482015107TRLO0.1.1

XLON

5

628.5

11/08/2025 08:29:54

00482015967TRLO0.1.1

AQXE

9

628.5

11/08/2025 08:29:54

00482015968TRLO0.1.1

AQXE

58

629

11/08/2025 08:41:09

00482020882TRLO0.1.1

BATE

139

629

11/08/2025 08:41:09

00482020883TRLO0.1.1

XLON

8

629

11/08/2025 08:45:03

00482022187TRLO0.1.1

BATE

50

629

11/08/2025 08:45:03

00482022188TRLO0.1.1

BATE

278

629

11/08/2025 08:45:03

00482022189TRLO0.1.1

XLON

3

628.5

11/08/2025 08:45:04

00482022195TRLO0.1.1

AQXE

13

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Mon, 11.08.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

11 August 2025

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback extension programme announced on 30 July 2025 (the Extended Programme), it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through Jefferies International Limited:

Date of purchase:

8 August 2025

Aggregate number of ordinary shares purchased:

38,000

Highest price paid per share (pence per share):

638.50p

Lowest price paid per share (pence per share):

628.00p

Volume weighted average price paid per share

(pence per share)

632.49.0p

The Company intends to cancel these Ordinary Shares.

Following the purchase, settlement and cancellation of these Ordinary Shares, the Company will have 177,058,701 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains the detailed breakdown of the individual trades made by Jefferies International Limited on behalf of the Company as part of the Programme.

Since the commencement of this Extended Programme, the Company has purchased a total of 251,703 Ordinary Shares. In addition to the 14,145,768 Ordinary Shares purchased under the Share Buyback Programme between March 2024 and July 2025, the Company has purchased a total of 14,397,471 Ordinary Shares.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Schedule of Purchases

Transaction Details:

Issuer name: Bodycote plc

ISIN: GB00B3FLWH99

LEI: 213800V93QFW53NB7Y29

Intermediary name: Jefferies International Limited

Intermediary code: JEFFGB2XXXX

Time zone: GMT

Currency: GBP

Individual Transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Transaction reference number

Venue

27

636

08/08/2025 08:18:45

00481821069TRLO0.1.1

CHIX

2

636

08/08/2025 08:18:45

00481821070TRLO0.1.1

CHIX

1

636

08/08/2025 08:18:45

00481821071TRLO0.1.1

CHIX

12

636

08/08/2025 08:18:45

00481821073TRLO0.1.1

CHIX

19

636

08/08/2025 08:18:45

00481821072TRLO0.1.1

CHIX

274

636.5

08/08/2025 08:18:45

00481821074TRLO0.1.1

XLON

5

636

08/08/2025 08:18:46

00481821078TRLO0.1.1

CHIX

9

635

08/08/2025 08:25:33

00481821656TRLO0.1.1

AQXE

12

635

08/08/2025 08:25:33

00481821655TRLO0.1.1

CHIX

9

635

08/08/2025 08:25:33

00481821659TRLO0.1.1

AQXE

18

635

08/08/2025 08:25:33

00481821658TRLO0.1.1

AQXE

21

635

08/08/2025 08:25:33

00481821657TRLO0.1.1

CHIX

137

635

08/08/2025 08:25:33

00481821660TRLO0.1.1

XLON

137

635

08/08/2025 08:25:33

00481821661TRLO0.1.1

XLON

411

635

08/08/2025 08:25:33

00481821662TRLO0.1.1

XLON

33

635

08/08/2025 08:27:30

00481821833TRLO0.1.1

CHIX

26

637.5

08/08/2025 08:42:32

00481823612TRLO0.1.1

XLON

33

637.5

08/08/2025 08:42:32

00481823614TRLO0.1.1

CHIX

52

637.5

08/08/2025 08:42:32

00481823613TRLO0.1.1

XLON

333

637.5

08/08/2025 08:42:32

00481823615TRLO0.1.1

XLON

137

637.5

08/08/2025 08:42:32

00481823616TRLO0.1.1

XLON

137

637.5

08/08/2025 08:44:18

00481823844TRLO0.1.1

XLON

33

637.5

08/08/2025 08:44:46

00481823870TRLO0.1.1

CHIX

15

637.5

08/08/2025 08:48:14

00481824141TRLO0.1.1

CHIX

18

637.5

08/08/2025 08:48:14

00481824142TRLO0.1.1

CHIX

137

637.5

08/08/2025 08:49:11

00481824226TRLO0.1.1

XLON

3

636.5

08/08/2025 08:49:15

00481824231TRLO0.1.1

AQXE

14

637.5

08/08/2025 08:52:34

00481824514TRLO0.1.1

XLON

27

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Fri, 08.08.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

8 August 2025

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback extension programme announced on 30 July 2025 (the Extended Programme), it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through Jefferies International Limited:

Date of purchase:

7 August 2025

Aggregate number of ordinary shares purchased:

40,000

Highest price paid per share (pence per share):

645.0p

Lowest price paid per share (pence per share):

640.0p

Volume weighted average price paid per share

(pence per share)

641.99p

The Company intends to cancel these Ordinary Shares.

Following the purchase, settlement and cancellation of these Ordinary Shares, the Company will have 177,096,701 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains the detailed breakdown of the individual trades made by Jefferies International Limited on behalf of the Company as part of the Programme.

Since the commencement of this Extended Programme, the Company has purchased a total of 213,703 Ordinary Shares. In addition to the 14,145,768 Ordinary Shares purchased under the Share Buyback Programme between March 2024 and July 2025, the Company has purchased a total of 14,359,471 Ordinary Shares.

This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Schedule of Purchases

Transaction Details:

Issuer name: Bodycote plc

ISIN: GB00B3FLWH99

LEI: 213800V93QFW53NB7Y29

Intermediary name: Jefferies International Limited

Intermediary code: JEFFGB2XXXX

Time zone: GMT

Currency: GBP

Individual Transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Transaction reference number

Venue

18

642

07/08/2025 08:12:10

00481664279TRLO0.1.1

BATE

75

642.5

07/08/2025 08:12:10

00481664278TRLO0.1.1

XLON

420

642.5

07/08/2025 08:12:10

00481664277TRLO0.1.1

XLON

16

642

07/08/2025 08:12:10

00481664281TRLO0.1.1

TRQX

40

642

07/08/2025 08:12:10

00481664280TRLO0.1.1

BATE

34

642.5

07/08/2025 08:12:17

00481664298TRLO0.1.1

CHIX

34

642.5

07/08/2025 08:14:36

00481664586TRLO0.1.1

CHIX

16

642

07/08/2025 08:14:52

00481664650TRLO0.1.1

TRQX

58

642

07/08/2025 08:14:52

00481664649TRLO0.1.1

BATE

34

642.5

07/08/2025 08:15:56

00481664868TRLO0.1.1

XLON

131

642.5

07/08/2025 08:15:56

00481664869TRLO0.1.1

XLON

34

643

07/08/2025 08:19:36

00481665432TRLO0.1.1

CHIX

62

643

07/08/2025 08:19:55

00481665480TRLO0.1.1

XLON

103

643

07/08/2025 08:19:55

00481665481TRLO0.1.1

XLON

165

643

07/08/2025 08:23:53

00481665963TRLO0.1.1

XLON

58

642

07/08/2025 08:26:05

00481666849TRLO0.1.1

BATE

34

643

07/08/2025 08:26:05

00481666848TRLO0.1.1

CHIX

16

642

07/08/2025 08:26:05

00481666850TRLO0.1.1

TRQX

165

642

07/08/2025 08:28:00

00481667209TRLO0.1.1

XLON

58

642

07/08/2025 08:28:32

00481667313TRLO0.1.1

BATE

16

642

07/08/2025 08:28:35

00481667321TRLO0.1.1

TRQX

165

642

07/08/2025 08:32:11

00481667998TRLO0.1.1

XLON

34

642.5

07/08/2025 08:33:00

00481668115TRLO0.1.1

CHIX

58

642

07/08/2025 08:33:31

00481668154TRLO0.1.1

BATE

81

642

07/08/2025 08:38:33

00481668976TRLO0.1.1

XLON

84

642

07/08/2025 08:38:33

00481668977TRLO0.1.1

XLON

26

642

07/08/2025 08:41:45

00481669475TRLO0.1.1

CHIX

9

642.5

07/08/2025 08:41:45

00481669476TRLO0.1.1

CHIX

59

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Wed, 30.07.2025 Bodycote

GB00B3FLWH99

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B3FLWH99

Issuer Name

BODYCOTE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

FMR LLC

City of registered office (if applicable)

Boston

Country of registered office (if applicable)

United States of America

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

29-Jul-2025

6. Date on which Issuer notified

30-Jul-2025

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.999900

0.000000

9.999900

17730963

Position of previous notification (if applicable)

10.002700

0.000000

10.002700

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B3FLWH99

17730963

9.999900

Sub Total 8.A

17730963

9.999900%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

FMR LLC

7.731600

0.000000

7.731600%

FMR LLC

Fidelity Management & Research Company LLC

7.731600

0.000000

7.731600%

FMR LLC

FIAM Holdings LLC

FMR LLC

FIAM LLC

FMR LLC

FMTC Holdings LLC

FMR LLC

Fidelity Management Trust Company

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

30-07-2025

13. Place Of Completion

Dublin, Ireland

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Wed, 30.07.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

30 July 2025

Bodycote plc

Extension of Share Buyback Programme

Bodycote plc (”Company”), the world's leading provider of heat treatment and specialist thermal processing services, today confirms its intention to further extend its share buyback programme, as originally announced on 15 March 2024 ('Programme'), by a further £30 million resulting in a total maximum aggregate consideration of £120 million being allocated to the Programme.

Having completed the third £30 million tranche on 9 July 2025, the Company has now entered into a further agreement with Jefferies International Limited ("Jefferies") to execute an additional £30 million share buyback as an extension to the original Programme (the 'Extended Programme') to start immediately. Under this arrangement, Jefferies will carry out on-market purchases of ordinary shares. Jefferies will make its trading decisions in relation to the Extended Programme independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject during the Extended Programme.

The Extended Programme will otherwise continue to be subject to the same parameters, and for the same purpose, as set out in the Company's original share buyback announcement issued on 15 March 2024, in particular with respect to the volume of shares that can be traded. The maximum number of shares which can be repurchased under the Programme is currently 17,949,908. The Extended Programme will be conducted at all times within the limits of the applicable authority granted by shareholders at the 2025 AGM to repurchase the Company's ordinary shares in issue. It is anticipated that the Extended Programme will end no later than end January 2026. The sole purpose of the Extended Programme is to reduce the Company's share capital and accordingly, the purchased ordinary shares will be cancelled.

This Extended Programme will be conducted in accordance with the Company's general authority to repurchase Ordinary Shares, Chapter 9 of the FCA’s Listing Rules, and in accordance with the parameters prescribed by the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). Share purchases in relation to the Extended Programme will be carried out on the open market via the London Stock Exchange and/or other recognised investment exchange(s) for the purposes of section 693 of the Companies Act 2006 and may be made from time to time depending on market conditions, share price, trading volume and other factors. Purchases may continue during any closed period to which the Company is subject during the engagement period.

About Bodycote

Bodycote is the world's largest provider of thermal processing services with a global footprint. Through Specialist Technologies and Precision Heat Treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including Aerospace, Defence, Automotive, Power Generation, Oil & Gas, Construction, Medical and Transportation. Customers have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Wed, 30.07.2025 Bodycote

GB00B3FLWH99

Bodycote plc – 2025 Interim Results

Strategic progress despite challenging end markets;

Full Year Outlook Unchanged

Group summary

Adjusted1

Statutory

Half year

2025

2024

Change

2025

2024

Change

Revenue

£369.0m

£399.0m

-7.5%

£369.0m

£399.0m

-7.5%

Operating profit

£55.1m

£66.8m

-17.5%

£41.2m

£30.8m

+33.8%

Operating margin

14.9%

16.7%

-180 bps

11.2%

7.7%

+350 bps

Operating cash flow

£37.7m

£49.2m

-23.4%

£65.8m

£71.7m

-8.2%

Basic earnings per share2

21.3p

25.0p

-14.8%

15.5p

10.2p

+52.0%

Interim dividend per share

6.9p

-

Core summary1

Half year

Organic

2025

2024

Change

Revenue

£351.9m

£374.6m

-3.6%

Adjusted operating profit

£54.3m

£65.9m

-14.7%

Adjusted operating margin

15.4%

17.6%

Excludes Non-core sites included in the original Optimise programme, as stated at the 2024 Capital Markets Event (CME).

Highlights

Performance in line with expectations provided in May trading update; full year outlook unchanged Market conditions remain challenging, though momentum improved through H1 with sequential growth seen in almost all end markets vs soft 2H24 (Core revenue +4.3%) Core revenue -3.6% YoY organically, impacted by weak Industrial and Automotive markets and delivery phasing in Specialist Technologies; Group revenue -4.6% YoY organically (-7.5% total) Adjusted operating profit of £55.1m (1H24: £66.8m), due to lower revenue, mix and FX impact; statutory operating profit higher at £41.2m (1H24: £30.8m) due to lower exceptional charges Adjusted operating margin of 14.9% (1H24: 16.7%) reflecting lower revenues and divisional mix Continued good progress on the Optimise, Perform and Grow strategy laid out at our 2024 CME Key Perform and Grow programmes underway, including roll-out of service quality initiatives and targeted capacity expansions for future growth Optimise programme enhanced: expected profit benefit increased to at least £15m (previously £12-14m) and net execution costs post-disposals materially reduced to £10-15m (vs. £25-30m) Remain confident in delivery of our medium term financial targets Additional £30m share buyback announced, enabled by strong balance sheet and low leverage Full year outlook unchanged and in line with market expectations.3 Macro environment remains uncertain; H2 profit improvement expected, reflecting Optimise benefits, continued Aerospace recovery and improved Specialist Technologies trading

Commenting, Jim Fairbairn, Chief Executive Officer, said:

“Trading has been in line with our expectations following our May update. Demand is strong in industrial gas turbines, as well as in Aerospace and Defence where supply chain conditions are improving. Automotive and Industrial markets remain weak but saw modest improvement versus a soft second half of 2024. We made significant progress on our Optimise, Perform & Grow strategy in the period. On Optimise, we are executing well on the original programme and expect execution costs to be lower than previously estimated. Due to this increased confidence in execution, as well as ongoing challenges in certain end markets, we have expanded the scope of the programme with additional sites and overhead actions. We have also entered into a contractual process to dispose of a package of Automotive and Industrial sites in France for around £20m in cash proceeds, helping to reduce programme costs. As a result of these changes, the programme will now deliver an increased annual profit benefit of at least £15m at a materially lower net cost of £10-15m.We also continue to deliver on Perform and Grow. In Perform, we are rolling out service quality initiatives which are demonstrating tangible early benefits. In Grow, we are investing in our target areas at the same time as improving our sales capability and service offering, which will help to drive an acceleration in our future growth. We have also made significant progress on sustainability, both to reduce our own emissions and improve our customer offering.Our full year guidance is unchanged and is in line with market expectations.3 While the macro environment remains uncertain, we expect higher profit in the second half underpinned by Optimise benefits, continued recovery in Aerospace, and improved Specialist Technologies performance as we deliver new contract wins. Our focus continues to be on controlling costs and executing on our strategy as we transition Bodycote into a higher quality, more resilient and faster growing business. We remain confident in delivering our medium term financial targets."

1 Adjusted performance measures and Core measures represent the statutory results excluding certain items; Organic measures are stated at constant currency excluding any acquisitions and disposals in the period. These are all considered alternative performance measures (APMs) and a reconciliation to the nearest IFRS equivalent to these measures is provided at the end of these 2025 Interim Results (hereafter ‘Report’).

2 An earnings per share reconciliation is provided in note 4 to the condensed consolidated interim financial statements.

3 Company-compiled consensus available at: https://www.bodycote.com/investors (FY25 operating profit range: £115.7-123.0m, mean: £119.9m)

END

Half Year Results Presentation

Bodycote will host a presentation for investors and analysts at 09.30 am BST on 30 July 2025. The presentation will also be webcast live. Please find connection instructions below:

Webcast: http://bodycote.com/interimwebcast2025

Conference call details:

United Kingdom (Local): +44 20 3936 2999

United Kingdom (Toll-Free): +44 808 189 0158

Global Dial-In Numbers

Access Code: 307359

Questions can be asked online via the webcast service. A recording will also be available after the event.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Group Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations & FP&A

Tel: +44 1625 505 300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

About Bodycote plc

Bodycote is the world's largest provider of thermal processing services with a global footprint. Through Specialist Technologies and Precision Heat Treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including Aerospace, Defence, Automotive, Power Generation, Oil & Gas, Construction, Medical and Transportation. Customers have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com.

Half Year Commentary

Core Overview

Core revenue reduced by 3.6% organically in H1 to £351.9m. This reflected continued weakness in Automotive and Industrial Markets, as well as delivery phasing in Specialist Technologies. By division, Specialist Technologies revenue declined by 7.7% organically, which included the expected impact of the end of Oil & Gas project work in 2024, as well as delivery phasing in HIP Product Fabrication (HIP PF). Momentum improved through the period with flat revenue YoY in May and June, and good growth is expected in H2 as we deliver on new order wins and the Aerospace volume recovery continues. Precision Heat Treatment was resilient given challenging end markets, with revenue down 1.8% organically, as the decline in Automotive and Industrial markets was partly offset by growth in industrial gas turbines, Aerospace & Defence, and Consumer, Medical & Other.

Core adjusted operating profit reduced to £54.3m (H1 2024: £65.9m) driven by lower revenue, alongside the mix effect of a lower share of revenue in Specialist Technologies. Central costs reduced by £1.7m organically, reflecting cost control actions as well as lower charges for share-based incentive pay. Core adjusted operating margins were 15.4% (H1 2024: 17.6%). In H2 we expect a higher level of both profit and margins, driven by improved Specialist Technologies trading as well as increased Optimise benefits, with the majority of the £4-5m full year profit benefit delivered in H2.

Group Overview

Including Non-core businesses, total Group revenue was £369.0m (H1 2024: £399.0m), 4.6% lower organically. This reflected the organic reduction in Core revenue, compounded by a 21.1% reduction in Non-core revenue as Optimise programme plant consolidations take effect. Group adjusted operating profit of £55.1m was down year-on-year (H1 2024: £66.8m) primarily reflecting the lower Core profit.

Group statutory operating profit was £41.2m in the period, up 33.8% from £30.8m in H1 2024. This included a lower level of exceptional charges in the period, including the non-repeat of a £28.3m ERP impairment in H1 2024, partly offset by additional charges relating to the Optimise programme.

Basic adjusted earnings per share was 21.3p (H1 2024: 25.0p), 14.8% lower year-on-year reflecting reduced profit partly offset by a lower share count due to the share buyback programme. The higher statutory profit resulted in improved statutory earnings per share of 15.5p (H1 2024: 10.2p).

Adjusted operating cash flow of £37.7m (H1 2024: £49.2m) was lower year-on-year, due to reduced profit and an increase in capital expenditure, partly offset by the non-repeat of a £6m one-off provision outflow in the prior year. Cash conversion remained healthy at 68% (H1 2024: 74%). Free cash flow of £18.0m was lower year-on-year (H1 2024: £26.0m) as lower adjusted operating cash flow and higher restructuring costs were partly offset by a lower level of cash tax, which was heavily H1-weighted in the prior year.

Closing net debt excluding lease liabilities was £112.5m, with leverage remaining low at 0.6x net debt / adj. EBITDA. Net debt excluding lease liabilities increased from £68.3m at year-end 2024, driven by payment of the full year dividend (£28.7m) and the share buyback programme (£30.9m) which more than offset free cash flow of £18.0m in the period.

Divisional Performance

Specialist Technologies

H1 2025

H1 2024

(restated)

Organic

Change

Revenue

105.6

116.3

-7.7%

-9.2%

Adjusted operating profit

27.0

34.2

-21.1%

Adjusted operating margin

25.6%

29.4%

-380bps

Precision Heat Treatment

H1 2025

H1 2024

(restated)

Organic

Change

Revenue

246.3

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Thu, 10.07.2025 Bodycote

GB00B3FLWH99

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B3FLWH99

Issuer Name

BODYCOTE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

FMR LLC

City of registered office (if applicable)

Boston

Country of registered office (if applicable)

United States of America

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

09-Jul-2025

6. Date on which Issuer notified

10-Jul-2025

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.002700

0.000000

10.002700

17735763

Position of previous notification (if applicable)

5.780000

0.000000

5.780000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B3FLWH99

0

17735763

0.000000

10.002700

Sub Total 8.A

17735763

10.002700%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

FMR LLC

7.733600

0.000000

7.733600%

FMR LLC

Fidelity Management & Research Company LLC

7.733600

0.000000

7.733600%

FMR LLC

FIAM Holdings LLC

FMR LLC

FIAM LLC

FMR LLC

FMTC Holdings LLC

FMR LLC

Fidelity Management Trust Company

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

10-Jul-2025

13. Place Of Completion

Dublin, Ireland.

14. Contact name: A Broughton, Company Secretary, Bodycote plc

15. Contact telephone number: +44 1625 505300

Bodycote

Technical Analysis Termsheet Terminal

Permalink

Thu, 10.07.2025 Bodycote

GB00B3FLWH99

www.bodycote.com

10 July 2025

Bodycote plc

Share Buyback Programme - Transactions in Own Securities

Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback extension programme announced on 20 December 2024 (the Extended Programme) it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through HSBC Bank PLC:

Date of purchase:

9 July 2025

Aggregate number of ordinary shares purchased:

21,743

Highest price paid per share (pence per share):569.5

611.5p

Lowest price paid per share (pence per share):

597.0p

Volume weighted average price paid per share

(pence per share)

604.8293p

The Company intends to cancel these Ordinary Shares.

Following the purchase, settlement and cancellation of these Ordinary Shares, the Company will have 177,310,404 Ordinary Shares in issue, with no shares held in treasury. This figure represents the total number of voting rights.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains the detailed breakdown of the individual trades made by HSBC Bank PLC on behalf of the Company as part of the Programme. This announcement is made in accordance with the requirements of UK Listing Rule 9.6.6.

Completion of the third tranche of the Share Buyback programme

Following the above transaction, the Company confirms that it has now completed the £30 million Extended Programme, which commenced on 15 January 2025. This is the third tranche of the Share Buyback Programme (the Programme) that was first announced on 15 March 2024. Under the Programme, a total of 14,145,768 ordinary shares have been purchased for cancellation at a volume weighted average price of 636.23p per ordinary share for a total consideration of £90 million.

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

Schedule of Purchases

Transaction Details:

Issuer name: Bodycote plc

ISIN: GB00B3FLWH99

LEI: 213800V93QFW53NB7Y29

Intermediary name: HSBC Bank PLC

Intermediary code: HBEU

Time zone: GMT

Currency: GBP

Individual Transactions:

Number of shares purchased

Transaction price (per share)

Time of transaction

Transaction reference

Venue

61

611.5